Investigational New Drug CDMO Market Size & Share Analysis - Growth, Trends and Forecasts (2024-2029)

The Investigational New Drug CDMO Market Report is Segmented by Product (Small Molecule, Large Molecule), Service (Contract Development and Contract Manufacturing), End User (Pharmaceutical Companies, Biotechnology Companies, and Others), and Geography (North America, Europe, Asia-Pacific, The Middle East and Africa, and South America). The Report Offers the Value (USD) for all the Above Segments.

Investigational New Drug CDMO Market Size & Share Analysis - Growth, Trends and Forecasts (2024-2029)

Investigational New Drug CDMO Industry Overview

The investigational new drug CDMO market is semi-consolidated, with several companies operating globally. Most companies are engaged in strategic activities like mergers and acquisitions, collaborations, and partnerships to sustain in the market. Some of the key players involved in the market are Lonza, Charles River Laboratories International Inc., Labcorp Corporation, Recipharm AB, and Syneous Health.

Investigational New Drug CDMO Market Leaders

  1. Lonza

  2. Charles River Laboratories International, Inc.

  3. Recipharm AB

  4. Syneous Health

  5. Labcorp Corporation

  6. *Disclaimer: Major Players sorted in no particular order
Investigational New Drug CDMO Market Concentration

Investigational New Drug CDMO Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?